Skip to main content
Brian Crompton, MD, Pediatric Hematology & Oncology, Boston, MA, Dana-Farber Cancer Institute

BrianD.CromptonMD

Pediatric Hematology & Oncology Boston, MA

Instructor in Pediatrics, Dana-Farber Cancer Institute

Dr. Crompton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Crompton's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 2003 - 2006
  • Boston University School of Medicine
    Boston University School of MedicineClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - Present
  • MA State Medical License
    MA State Medical License 2010 - 2024
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Journal Articles

  • Integrated Genetic and Pharmacologic Interrogation of Rare Cancers  
    Andrew L Hong, Katherine A Janeway, Brian D Crompton, Kimberly Stegmaier, Levi A Garraway, Alanna J Church, Stuart L Schreiber, William C Hahn, Nature

Press Mentions

  • Pediatric Cancer Research Foundation Announces 2023 Grant Recipients to Accelerate Discovery of New Treatments for Pediatric Cancers
    Pediatric Cancer Research Foundation Announces 2023 Grant Recipients to Accelerate Discovery of New Treatments for Pediatric CancersMay 26th, 2023
  • Chemical Screening Suggests a Two-Pronged Treatment for Paediatric Ewing Sarcoma
    Chemical Screening Suggests a Two-Pronged Treatment for Paediatric Ewing SarcomaAugust 15th, 2019
  • Chemical Screening Suggests a Two-Pronged Treatment for Pediatric Ewing Sarcoma
    Chemical Screening Suggests a Two-Pronged Treatment for Pediatric Ewing SarcomaAugust 14th, 2019

Hospital Affiliations